Letter: should we delay surgery, or stop anti-TNF therapy prior to elective surgical procedures in Crohn's disease patients receiving anti-TNF agents? Authors' reply.

Lin, Yang-Sheng; Chen, Ming-Jen; Lin, Wei-Chen; Wang, Yuan-Hung; Chen, Chiehfeng

Lin, Yang-Sheng; Chen, Ming-Jen; Lin, Wei-Chen; Wang, Yuan-Hung; Chen, Chiehfeng.

Afiliación

Lin YS; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chen MJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
Lin WC; MacKay Medical College, New Taipei City, Taiwan.
Wang YH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
Chen C; MacKay Medical College, New Taipei City, Taiwan.

Aliment Pharmacol Ther ; 50(8): 970-971, 2019 10.

Article en En | MEDLINE | ID: mdl-31591780

Asunto(s)

Enfermedad de Crohn/cirugía; Adalimumab; Procedimientos Quirúrgicos Electivos; Humanos; Infliximab; Factor de Necrosis Tumoral alfa

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2019 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google